Our Products

See our range of cfDNA products below.


Ensuring successful cfDNA analysis is our focus

Every sample is precious and to get the most out of your sample when evaluating cfDNA it is really critical to have processed your samples correctly from blood collection through to extracted cfDNA. Learn more about our Cell3 Preserver blood tube and Cell3 Xtract kit below.

Prenatal Healthcare

Non-invasive prenatal testing requires sensitive, reproducible and easy to use products.

Nonacus continues to develop innovative products to meet these exacting standards including tests for fetal rhesus-D genotyping, fetal fraction quantitation and single gene disorder testing.


Efficient workflow enables confident calling of all ctDNA mutations

Nonacus are working with some of the brightest scientists and clinicians by providing a validated complete workflow for liquid biopsy analysis. With the ultimate goal of enabling better cancer care through earlier diagnosis, treatment stratification and monitoring.

Who we are

Designed by scientists, for Scientists

We are formed of a committed group of biotechnology professionals with a combined 35 years experience in genomic healthcare. We understand the pressure on laboratories to deliver progress and our products are designed to get you there. Between us, we’ve got global experience of genomic healthcare from the NHS in the UK through to an international genome project.

Designed by scientists
True Innovation

What we stand for

True Innovation That Benefits Patients

We translate research into routine diagnostic tools that directly benefit patients and scientists. Our non-invasive cell free DNA solutions improve diagnostic accuracy as well as the patient’s experience. Our research & development team are constantly developing, validating and testing new cfDNA products.

Built For Labs That Do


We supply Universities with our cfDNA products to help them improve their understanding and research in non-invasive healthcare.


Leading hospitals have adopted our products to help improve patient care through the innovative use of cfDNA technology allowing for non-invasive diagnostics.

Research Facilities

We partner with many leading laboratories to constantly innovate and push our products further.

Research Facilities

Read Our Latest Insights

Detecting multiple respiratory viruses

Detecting multiple respiratory viruses with a single qRT-PCR assay

March 16, 2022

As some of the symptoms of COVID-19 overlap with flu and respiratory syncytial virus (RSV), a negative COVID test result doesn’t always give the full picture of infection. Testing for multiple respiratory viruses in one simple qRT-PCR test could be the answer.

Read More

Unique molecular identifiers: the key to unmasking real low frequency variants

January 28, 2022

How molecular barcodes help remove PCR and sequencing errors that can mask important low-frequency variations in the analysis of cell-free DNA.

Read More

Tumour Mutational Burden (TMB) and Microsatellite Instability (MSI) as markers for immunotherapy response

December 22, 2021

Immune-checkpoint inhibitor (ICI) therapies have heralded promise of a superior drug response and significantly increased survival for a small proportion of cancer patients across a range of cancers.

Read More

Upcoming Events

European Congress of Pathology

3-7 September 2022

Congress Centre, Basel

Basel, Switzerland

Genomics Live - BioTechX

8-10 November 2022

Congress Centre, Basel

Basel, Switzerland

Are you ready to innovate your cfDNA capability?

Contact us for a quote.